EquityZen Growth Technology Fund LLC - Series 2248
Raised
$971K
Investors
28
Min Invest
$10,028
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 2248 is a Delaware-based pooled investment fund filed by EquityZen Advisors LLC and Philip Haslett on 2026-03-27. The fund raised $971K from 28 investors with a $10K minimum investment under Rule 506(b) and 3(c)(1) exemptions. This is part of EquityZen's pre-IPO platform comprising 1,889 related EDGAR entities.
This pre-IPO pooled fund employs the standard 506(b)/3(c)(1) exemption structure typical of EquityZen's series vehicle platform, with a $10K retail-accessible minimum. The $34.7K average investment per investor reflects the platform's democratized access model to late-stage private company equity.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
